Liquidia Corp. (LQDA)
70.28
+1.66
(+2.41%)
USD |
NASDAQ |
Aug 24, 16:00
70.28
0.00 (0.00%)
After-Hours: 20:00
Liquidia Profit Margin (Quarterly) : 43.52% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 43.52% |
| March 31, 2026 | 39.79% |
| December 31, 2025 | 15.82% |
| September 30, 2025 | -6.50% |
| June 30, 2025 | -470.5% |
| March 31, 2025 | -1.23K% |
| December 31, 2024 | -1.32K% |
| September 30, 2024 | -697.6% |
| June 30, 2024 | -783.5% |
| March 31, 2024 | -1.01K% |
| December 31, 2023 | -605.8% |
| September 30, 2023 | -429.3% |
| June 30, 2023 | -491.4% |
| March 31, 2023 | -261.4% |
| December 31, 2022 | -121.9% |
| September 30, 2022 | -287.3% |
| June 30, 2022 | -241.1% |
| March 31, 2022 | -456.6% |
| December 31, 2021 | -359.7% |
| Date | Value |
|---|---|
| September 30, 2021 | -229.1% |
| June 30, 2021 | -194.1% |
| March 31, 2021 | -297.8% |
| December 31, 2020 | -2.18K% |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | -73.11% |
| March 31, 2019 | |
| December 31, 2018 | -1.70K% |
| September 30, 2018 | -5.70K% |
| June 30, 2018 | -601.1% |
| March 31, 2018 | -2.97K% |
| December 31, 2017 | |
| September 30, 2017 | -1.06K% |
| June 30, 2017 | -418.3% |
| March 31, 2017 | -600.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | 35.57% |
| Harmony Biosciences Holdings, Inc. | 28.87% |
| Johnson & Johnson | 21.86% |
| Amneal Pharmaceuticals, Inc. | 8.74% |
| Corcept Therapeutics, Inc. | 16.45% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 179.7% |
| Return on Assets | 38.75% |
| Return on Invested Capital | 53.03% |
| Gross Profit Margin (Quarterly) | 93.10% |
| Operating Margin (Quarterly) | 49.81% |
| Return on Net Operating Assets | 127.3% |